News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
Presentation TCT 2023 TCT 528: Procedural Complications and Outcomes in Patients with Hypertrophic Obstructive Cardiomyopathy Undergoing Septal Myomectomy Versus Alcohol Septal Ablation. Presenter: Ndausung Udongwo October 26, 2023
Presentation TCT 2023 TCT 421: Permanent Pacemaker Following Alcohol Septal Ablation – Prevalence of Utilization at 1 Year? Presenter: Michael Bashline October 26, 2023
Presentation TCT 2023 Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: One Year Results of the REBALANCE-HF Roll-in Cohort Presenter: Sheldon Litwin October 26, 2023
News Conference News HFSA 2023 REBALANCE-HF Uncovers HFpEF Group That Responds to Splanchnic Nerve Ablation Todd Neale October 11, 2023
News Daily News Subclinical HFpEF Common in Patients Undergoing AF Ablation Todd Neale September 08, 2023
News Conference News ESC 2023 CASTLE-HTx: AF Ablation Boosts Outcomes in Advanced Heart Failure Todd Neale August 28, 2023
News Opinion Editor's Corner ESC 2023 What’s Going to Be Hot at ESC 2023? Shelley Wood August 15, 2023
News Conference News EuroPCR 2023 Renal Denervation: Exploring Its Potential Beyond Hypertension Todd Neale May 18, 2023
News Features Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar L.A. McKeown May 12, 2023
News Conference News EHRA 2023 Novel Score Identifies HF Patients With AF Who Respond to Ablation Michael O'Riordan April 19, 2023
News Conference News THT 2023 Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF Todd Neale March 22, 2023
Presentation THT 2023 Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: Updated Results of the REBALANCE-HF Trial Roll-in Cohort Presenter: Marat Fudim March 21, 2023